Sunil Agarwal

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial

Paul Emery, Roy Fleischmann, Anna Filipowicz‐Sosnowska et al. · Arthritis & Rheumatism · 2006 · 1.1K citations

Medicine, Internal Medicine, Pharmacotherapy +13

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

Álvaro Alonso, Bouwe P. Krijthe, Thor Aspelund et al. · Journal of the American Heart Association · 2013 · 886 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors

Rachel Huxley, Faye L. Lopez, Aaron R. Folsom et al. · Circulation · 2011 · 707 citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Cem Gabay, Paul Emery, Ronald van Vollenhoven et al. · The Lancet · 2013 · 673 citations

Life Sciences, Immunology, Pharmacotherapy +13

Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study

Álvaro Alonso, Sunil Agarwal, Elsayed Z. Soliman et al. · American Heart Journal · 2009 · 536 citations

Medicine, Cardiology, Preventive Medicine +11